NCT02090764View on ClinicalTrials.gov

Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

PHASE3CompletedINTERVENTIONAL
Enrollment

412

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Impetigo
Interventions
DRUG

Ozenoxacin

DRUG

Placebo

Trial Locations (1)

Unknown

Caparra Internal Medicine Center, Río Grande

All Listed Sponsors
lead

Ferrer Internacional S.A.

INDUSTRY

NCT02090764 - Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo | Biotech Hunter | Biotech Hunter